IWM
REGN icon

IMG Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

IMG Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.32K Sell
3
-7
-70% -$5.36K ﹤0.01% 432
2025
Q4 		$7.72K Buy
10
+1
+11% +$679 ﹤0.01% 353
2025
Q3 		$5.06K Hold
9
– – ﹤0.01% 352
2025
Q2 		$4.72K Buy
+9
New +$5.02K ﹤0.01% 352

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IMG Wealth Management's REGN Position: Q1 2026 in Review

IMG Wealth Management reduced its Regeneron Pharmaceuticals (REGN) stake by 70% in Q1 2026, selling an estimated $5.36K and leaving 3 shares worth $2.32K. The position accounts for ﹤0.01% of the portfolio, ranked #432.

IMG Wealth Management first reported a position in REGN in Q2 2025 and has held it in 4 quarters since. The position peaked at $7.72K in Q4 2025. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • IMG Wealth Management held 3 shares of Regeneron Pharmaceuticals worth $2.32K as of Q1 2026.
  • IMG Wealth Management sold 7 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $5.36K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of IMG Wealth Management's portfolio in Q1 2026, its #432 holding.
  • IMG Wealth Management first reported a position in Regeneron Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • IMG Wealth Management's Regeneron Pharmaceuticals position peaked at $7.72K in Q4 2025.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on IMG Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.